RS2207132 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Low density lipoprotein cholesterol levels | A | OR: 0.15 | 3E-108 | PubMed |
| Total cholesterol levels | A | OR: 0.14 | 9E-97 | PubMed |
| Apolipoprotein B levels | A | OR: 0.13 | 2E-86 | PubMed |
| Serum alkaline phosphatase levels | A | β: 0.078 | 8E-31 | PubMed |
| Total cholesterol levels | — | OR: 0.17 | 3E-27 | PubMed |
| Cholesterol esters in very small VLDL | A | OR: 0.12 | 5E-27 | PubMed |
| Medication use (HMG CoA reductase inhibitors) | A | OR: 0.16 | 1E-24 | PubMed |
| Total cholesterol levels | G | OR: 0.12 | 2E-22 | PubMed |
| Low density lipoprotein cholesterol levels | G | OR: 0.12 | 1E-21 | PubMed |
| C-reactive protein levels (MTAG) | A | β: 0.054 | 7E-21 | PubMed |
| triglyceride (maximum, inv-norm transformed) | G | OR: 0.12 | 6E-20 | PubMed |
| Triglyceride levels | A | β: 0.061 | 1E-19 | PubMed |
| triglyceride (mean, inv-norm transformed) | G | OR: 0.12 | 3E-19 | PubMed |
| Omega-3 fatty acids levels | A | OR: 0.1 | 3E-19 | PubMed |
| Sex hormone-binding globulin levels adjusted for BMI | G | β: 0.028 | 9E-18 | PubMed |
| Docosahexaenoic acid (22:6) levels | A | β: 0.097 | 1E-17 | PubMed |
| Familial combined hyperlipidemia defined by Consensus criteria | G | OR: 0.18 | 2E-17 | PubMed |
| Triglyceride levels (MTAG) | A | β: 0.058 | 4E-17 | PubMed |
| C-reactive protein levels | G | β: 0.047 | 4E-17 | PubMed |
| Waist-to-hip ratio adjusted for BMI | A | β: 0.047 | 5E-17 | PubMed |